TFAP2Β overexpression, for instance, has been implicated not only as a protective or favourable prognostic factor in several cancers like breast, renal cell, cervical and endometrial cancers but also as a poor prognostic factor in thyroid cancer and lung adenocarcinoma [214–225] (See Table 1). This evidence concerns the gene TFAP2A and cancer.